The effect of pre-existing HLA sensitization on the renal allograft function according to angionephroscintigraphy results

An important role in assessing the transplanted kidney function recovery and diagnosing posttransplant complications belongs to angionephroscintigraphy allowing a qualitative and quantitative assessment of renal perfusion, filtration, and excretion. The aim of the study was to evaluate and monitor the allograft function after cadaveric kidney transplantation by using angionephroscintigraphy with 99mTc-Pentatech and studying the obtained results in relation to pre-existing HLA sensitization. We analyzed the results of radionuclide tests of 55 patients in the early postoperative period in time from 5 days to 3 months after transplantation. In most patients, the higher was the blood anti-HLA antibody levels in the recipient before the kidney transplantation, the more pronounced decrease in the function was noted in them according to angionephroscintigraphy results. In the treatment of patients with a primary allograft function, the function of the transplanted kidney had gradually improved by the 3–4th week, reaching normal values in a number of parameters. In patients with a delayed allograft function, only partial recovery of function was observed after 3–4 weeks. In that case, when a high level of preexisting anti-HLA antibodies had been noted, an abrupt decline in perfusion typical for an acute rejection crisis, and the filtration impairment were seen, often there was an impaired excretion, indicating a concomitant severe ischemic injury of the kidney or acute tubular necrosis. Thus, angionephroscintigraphy enables to assess the recovery of the graft function thanks to a separate evaluation of the function components, and in combination with the test for preexisting anti-HLA antibodies, helps to make a differential diagnosis of an acute rejection crisis and acute tubular necrosis allowing the choice of an adequate treatment tactics.

1. Mettler F.A. Jr., Guiberteau M.J. Essentials of nuclear medicine imaging. 6th ed. Elsevier Science, 2012. 315–344.

2. Kim E., Lee D., Tateishi U., Baum R. Handbook of nuclear medicine and molecular imaging: Principles and clinical applications. World Scientific Publ., 2012. 267–292.

3. Cook G.J.R., Maisey M.N., Britton K.E., Chengazi V., eds. Clinical Nuclear Medicine. 4th ed. London: Hodder Arnold, 2006. 296–327.

4. Yanishi M., Kinoshita H., Yoshida T., et al. Comparison of renal scintigraphy and computed tomographic renal volumetry for determining split renal function and estimating post-transplant renal function. Transplant Proc. 2015;47(9):2700– 2702. PMID:26680075 DOI:10.1016/j. transproceed.2015.07.037

5. Yazici B., Oral A., Gokalp C., et al. Evaluation of renal transplant scintigraphy and resistance index performed within 2 days after transplantation in predicting long-term graft function. Clin Nucl Med. 2015;40(7):548–552. PMID:25899587 DOI:10.1097/RLU.0000000000000789

6. Ayaz S., Gençoğlu EA., Moray G., et al. Evaluation of effects of recipient/donor gender on early/late postoperative renal graft functions by renal scintigraphy. Exp Clin Transplant. 2014;12(6):510– 514. PMID:24918693 DOI:10.6002/ ect.2013.0275

7. Durand E., Blaufox MD., Britton KE., et al. International scientific committee of radionuclides in nephrourology (ISCORN) consensus on renal transit time measurements. Semin Nucl Med. 2008;38(1):82–102. PMID:18096466 DOI:10.1053/j.semnuclmed.2007.09.009

8. Murthy R., Chahal M., Appel G., et al. Exercise acutely increases renal transit time of Ts-99m mercaptoacetyltrigly-cine (MAG 3) in a post-liver transplant patient. Clin Nucl Med. 2006;31(12):829– 834. PMID:17117088 DOI:10.1097/01. rlu.0000247736.14647.ac

9. Lishmanov Yu.B., Chernov V.I., eds. National guidelines on radionuclide diagnostics: in 2 volumes. Tomsk: STT Publ., 2010. V. 2: 190–215. (In Russian).

10. Borovkova N.V., Doronina N.V., Pin-chuk A.V. Identification of antibodies to HLA in kidney transplantation: selection of a donor for a sensitized recipient. Medical alphabet. Modern laboratory. 2014;4(22):35–38. (In Russian).

11. Hilson A.J.W., Maisey M.N., Brown C.B., et al. Dynamic renal transplant imaging with Ts-99m DTPA (Sn) supplemented by transplant perfusion index in the management. J Nucl Med. 1978;19(9):994–1000. PMID:357687

12. Nimmon C.C., Samal M., Britton K.E. Elimination of the influence of total renal function on renal output efficiency and normalized residual activity. J Nucl Med. 2004;45(4):587–593. PMID:15073254

13. Prigent A., Cosgriff P., Gates G.F., et al. Consensus report on quality control of quantitative measurements of renal function obtained from the reno-gram: international consensus committee of radionuclides in nephrourology. Semin Nucl Med. 1999;29(2):146–159. PMID:10321826